| Microorganism |
|
|
|
| Antimicrobial |
 |
|
Reference |
| Staphylococcus haemolyticus |
>0.015 |
>2 |
≤0.015 － >2 |
Rifampicin (Rifampin) |
123 |
| Staphylococcus haemolyticus |
0.03 |
128 |
≤0.007 － >128 |
Imipenem |
113 |
| Staphylococcus haemolyticus |
0.06 |
4 |
0.03 － 8 |
Garenoxacin (T-3811, BMS-284756) |
225 |
| Staphylococcus haemolyticus |
>0.12 |
>8 |
≤0.06 － >8 |
Clindamycin (Cleocin) |
472 |
| Staphylococcus haemolyticus |
0.125 |
0.5 |
0.06 － 0.5 |
PD 0305970 |
225 |
| Staphylococcus haemolyticus |
0.125 |
4 |
0.06 － 8 |
Gatifloxacin (Tequin) |
225 |
| Staphylococcus haemolyticus |
0.25 |
0.5 |
0.03 － 1 |
Daptomycin + 50 μg/ml Ca++ |
67 |
| Staphylococcus haemolyticus |
0.25 |
0.5 |
0.03 － 1 |
Daptomycin + 75 μg/ml Ca++ |
67 |
| Staphylococcus haemolyticus |
0.25 |
0.5 |
0.03 － 1 |
Tigecycline (GAR-936, Tigacyl) |
472 |
| Staphylococcus haemolyticus |
0.25 |
0.5 |
0.06 － 2 |
Daptomycin (Cubicin) |
472 |
| Staphylococcus haemolyticus |
0.25 |
0.5 |
0.06 － 2 |
Daptomycin (Cubicin) |
472 |
| Staphylococcus haemolyticus |
0.25 |
0.5 |
≤0.06 － 8 |
Minocycline (Minocycline hydrochloride, Minocin) |
462 |
| Staphylococcus haemolyticus |
0.25 |
0.5 |
≤0.25 － >8 |
Quinupristin/Dalfopristin (Synercid) |
472 |
| Staphylococcus haemolyticus |
0.25 |
1 |
0.125 － 1 |
PD 0326448 |
225 |
| Staphylococcus haemolyticus |
0.25 |
32 |
0.06 － 64 |
Levofloxacin (Levaquin, Quixin) |
225 |
| Staphylococcus haemolyticus |
0.5 |
1 |
0.015 － 4 |
Besifloxacin (Besivance) |
1467 |
| Staphylococcus haemolyticus |
0.5 |
1 |
0.03 － 2 |
Daptomycin + 25 μg/ml Ca++ |
67 |
| Staphylococcus haemolyticus |
0.5 |
1 |
0.12 － 1 |
Tigecycline (GAR-936, Tigacyl) |
462 |
| Staphylococcus haemolyticus |
1 |
1 |
0.12 － 2 |
Linezolid (PNU-100766, U-100766, Zyvox) |
472 |
| Staphylococcus haemolyticus |
>1 |
>1 |
≤0.5 － >1 |
Co-trimoxazole (Trimethoprim-sulfamethoxazole, TMP-SMX) |
123 |
| Staphylococcus haemolyticus |
1 |
2 |
0.25 － 4 |
Vancomycin (Vancocyn, Lyphocin) |
472 |
| Staphylococcus haemolyticus |
>1 |
>2 |
≤0.5 － >2 |
Co-trimoxazole (Trimethoprim-sulfamethoxazole, TMP-SMX) |
472 |
| Staphylococcus haemolyticus |
1 |
2 |
0.5 － 4 |
Vancomycin (Vancocyn, Lyphocin) |
67 |
| Staphylococcus haemolyticus |
1 |
2 |
? － ? |
Ceftobiprole (Zeftera) |
942 |
| Staphylococcus haemolyticus |
1 |
4 |
0.5 － 4 |
Vancomycin (Vancocyn, Lyphocin) |
123 |
| Staphylococcus haemolyticus |
1 |
8 |
0.015 － >8 |
Moxifloxacin (BAY 12-8039, Avelox) |
1467 |
| Staphylococcus haemolyticus |
>1 |
>8 |
0.12 － >8 |
Tetracycline (Sumycin, Achromycin V, Steclin) |
462 |
| Staphylococcus haemolyticus |
1 |
16 |
0.25 － >64 |
Teicoplanin (Targocid) |
67 |